$1.5B deal: AstraZeneca sells U.S. rights to respiratory medicine By: Philadelphia Business Journal via Business Journals November 13, 2018 at 10:47 AM EST AstraZeneca's deal to sell the U.S. rights to Synagis to a Swedish biopharmaceutical company is expected to be finalized early next year. Read More >>